Abstract
Antimicrobial peptides (AMPs) are considered ideal antibiotic candidates, but their therapeutic ability and application are restricted by their limited formulation. Nanoliposome encapsulation can lower the haemolytic toxicity of drugs. CGA-N9, a peptide derived from chromogranin A, is an AMP with high antifungal activity against Candida tropicalis. Herein, CGA-N9-encapsulated nanoliposomes were prepared and characterized, and their antagonistic activity against C. tropicalis and haemolytic activity were studied. The results showed that the CGA-N9 nanoliposomes had a particle size of 127.5 ± 12.8 nm and an encapsulation efficiency of 87.9%, as determined by the high-performance liquid chromatography (HPLC) method established herein. The minimum inhibitory concentration (MIC) of the CGA-N9 nanoliposomes was 7.8 μg/mL, which was higher than that of free CGA-N9 (3.9 μg/mL), and no haemolysis was detected at the maximum concentration tested (250 μg/mL). These results provide an experimental reference for the practical use of peptides in the clinic.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10989-021-10286-w/MediaObjects/10989_2021_10286_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10989-021-10286-w/MediaObjects/10989_2021_10286_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10989-021-10286-w/MediaObjects/10989_2021_10286_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10989-021-10286-w/MediaObjects/10989_2021_10286_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10989-021-10286-w/MediaObjects/10989_2021_10286_Fig5_HTML.jpg)
Similar content being viewed by others
Data Availability
All data generated or used during the study are included in the submitted article.
References
Aibani N, Khan TN, Callan B (2020) Liposome mimicking polymersomes; a comparative study of the merits of polymersomes in terms of formulation and stability. Int J Pharm X 2:100040. https://doi.org/10.1016/j.ijpx.2019.100040
Allen TM, Cullis PR (2013) Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65(1):36–48. https://doi.org/10.1016/j.addr.2012.09.037
Boge L, Bysell H, Ringstad L, Wennman D, Umerska A, Cassisa V, Eriksson J, Joly-Guillou M-L, Edwards K, Andersson M (2016) Lipid-based liquid crystals as carriers for antimicrobial peptides: phase behavior and antimicrobial effect. Langmuir 32(17):4217–4228. https://doi.org/10.1021/acs.langmuir.6b00338
Caltagirone C, Falchi AM, Lampis S, Lippolis V, Meli V, Monduzzi M, Prodi L, Schmidt J, Sgarzi M, Talmon Y, Bizzarri R, Murgia S (2014) Cancer-cell-targeted theranostic cubosomes. Langmuir 30(21):6228–6236. https://doi.org/10.1021/la501332u
Divyashree M, Mani MK, Reddy D, Kumavath R, Ghosh P, Azevedo V, Barh D (2019) Clinical applications of antimicrobial peptides (AMPs): where do we stand now? Protein Pept Lett 27(2):120–134. https://doi.org/10.2174/0929866526666190925152957
Gentilucci L, de Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16:3185–3203. https://doi.org/10.2174/138161210793292555
Gontsarik M, Buhmann MT, Yaghmur A, Ren Q, Maniura-Weber K, Salentinig S (2016) Antimicrobial peptide-driven colloidal transformations in liquid-crystalline nanocarriers. J Phys Chem Lett 7(17):3482–3486. https://doi.org/10.1021/acs.jpclett.6b01622
Hancock REW, Sahl H-G (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551–1557. https://doi.org/10.1038/nbt1267
Lee Y, Puumala E, Robbins N, Cowen LE (2021) Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev 121(6):3390–3411. https://doi.org/10.1021/acs.chemrev.0c00199
Li R, Chen C, Zhang B, Jing H, Wang Z, Wu C, Hao P, Kuang Y, Yang M (2019a) The chromogranin A-derived antifungal peptide CGA-N9 induces apoptosis in Candida tropicalis. Biochem J 476:3069–3080. https://doi.org/10.1042/BCJ20190483
Li R, Chen C, Zhu S, Wang X, Yang Y, Shi W, Chen S, Wang C, Yan L, Shi J (2019b) CGA-N9, an antimicrobial peptide derived from chromogranin A: direct cell penetration of and endocytosis by Candida tropicalis. Biochem J 476:483–497. https://doi.org/10.1042/BCJ20180801
Matougui N, Boge L, Groo AC, Umerska A, Ringstad L, Bysell H, Saulnier P (2016) Lipid-based nanoformulations for peptide delivery. Int J Pharm 502:80–97. https://doi.org/10.1016/j.ijpharm.2016.02.019
Meikle TG, Zabara A, Waddington LJ, Separovic F, Drummond CJ, Conn CE (2017) Incorporation of antimicrobial peptides in nanostructured lipid membrane mimetic bilayer cubosomes. Colloids Surf B Biointerfaces 152:143–151. https://doi.org/10.1016/j.colsurfb.2017.01.004
Mulet X, Conn CE, Fong C, Kennedy DF, Moghaddam MJ, Drummond CJ (2013) High-throughput development of amphiphile self-assembly materials: fast-tracking synthesis, characterization, formulation, application, and understanding. Acc Chem Res 46(7):1497–1505. https://doi.org/10.1021/ar300285u
Neshani A, Sedighian H, Mirhosseini SA, Ghazvini K, Zare H, Jahangiri A (2020) Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections. Microb Pathog 146:104–238. https://doi.org/10.1016/j.micpath.2020.104238
Qu MH, Zeng RF, Fang S, Dai QS, Li HP, Long JT (2014) Liposome-based codelivery of siRNA and docetaxel for the synergistic treatment of lung cancer. Int J Pharm 474(1–2):112–122. https://doi.org/10.1016/j.ijpharm.2014.08.019
Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y (2003) Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 86:235–242. https://doi.org/10.1016/s0168-3659(02)00411-x
Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y (2005) Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 303:160–170. https://doi.org/10.1016/j.ijpharm.2005.06.028
Tan J, Tay J, Hedrick J, Yang YY (2020) Synthetic macromolecules as therapeutics that overcome resistance in cancer and microbial infection. Biomaterials 252:120078. https://doi.org/10.1016/j.biomaterials.2020.120078
Verma G, Hassan PA (2013) Self assembled materials: design strategies and drug delivery perspectives. Phys Chem Phys 15(40):17016–17028. https://doi.org/10.1039/c3cp51207j
Volkov GL, Havryliuk SP, Krasnobryzha IM, Havryliuk OS (2017) The protein/peptide direct virus inactivation during chromatographic process: developing approaches. Appl Biochem Biotechnol 181(1):233–249. https://doi.org/10.1007/s12010-016-2209-2
Wan H, Lee KS, Kim BY, Yuan M, Zhan S, Lu Y, You H, Li J, Jin BR (2013) Developmental regulation and antifungal activity of a growth-blocking peptide from the beet armyworm Spodoptera exigua. Dev Comp Immunol 41:240–247. https://doi.org/10.1016/j.dci.2013.05.016
Xu H, Ohulchanskyy TY, Yakovliev A, Zinyuk R, Song J, Liu L, Qu J, Yuan Z (2019) Nanoliposomes co-encapsulating CT imaging contrast agent and photosensitizer for enhanced, imaging guided photodynamic therapy of cancer. Theranostics 9(5):1323–1335. https://doi.org/10.7150/thno.31079
Yang SY (2019) Development and pharmacokinetics study of antifungal peptide nanoliposomes by liquid chromatography-tandem mass spectrometry. Curr Pharm Anal 15(4):312–318. https://doi.org/10.2174/1573412914666180307155328
Yang SY, Zhu WS, Wang ZW, Xiao YM, Mao P, Qu LB, Hu YS, Wang JS (2020) Thermosensitive liposomes encapsulating anti-cancer agent lomustine, and contrast medium lohexol, for thermochemotherapy: preparation, characterization, and in vivo evaluation. J Nanosci Nanotechnol 20(10):6070–6076. https://doi.org/10.1166/jnn.2020.18590
Zhang N, Ping QN, Huang GH, Xu WF (2005) Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 294:247–259. https://doi.org/10.1016/j.ijpharm.2005.01.018
Funding
This study was funded by the National Natural Science Foundation of China (31572264, 31071922); the Innovative Research Team (in Science and Technology) at the University of Henan Province (19IRTSTHN008); the Innovative Funds Plan of Henan University of Technology (2020ZKCJ23); the Science and Technology Department of Henan Province (212102311045, 212102310322).
Author information
Authors and Affiliations
Contributions
RL and BZ proposed the study. LH, XW and LZ performed the experiments. RL and BZ performed the statistical analysis. RL drafted the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
Liang Huang declares that he has no conflicts of interest. Ruifang Li declares that she has no conflicts of interest. Xueqin Wang declares that she has no conflict of interest. Lan Zhang declares that she has no conflicts of interest. Beibei Zhang declares that she has no conflicts of interest.
Ethical Approval
This article does not contain any studies involving animals that were performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huang, L., Li, R., Wang, X. et al. Preparation and Characterization of Nanoliposomes Loaded with the Antimicrobial Peptide CGA-N9. Int J Pept Res Ther 27, 2727–2734 (2021). https://doi.org/10.1007/s10989-021-10286-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-021-10286-w